Abstract
Hopkins and colleagues [1] report the use of decellularized pulmonary homograft patch material in 106 patients, predominantly for pulmonary arterioplasty. No material related failure or reoperation was noted at 1.8-year follow-up. A historical group of 100 patients, having mostly cryopreserved or polytetrafluoroethylene (PTFE) patches for pulmonary arterioplasty, served as controls. The overall reintervention incidence was similar (17% study group versus 14% control group). Material failure was noted as the cause of reintervention in the control group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
